Saturday 17 October 2026
Export CON’s income statement to Excel — free account
Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 10.0%, EPS grew 45.7%, free cash flow grew 91.6% and total debt fell 5.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
38.54
0.61
−1.56%
Follow CON
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | 18.89 | 18.55 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | 24.81 | 24.17 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 11,000 | 11,250 | 13,133 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 0.17 | 0.17 | 0.16 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 1,732 | 1,724 | 1,838 | 1,900 | 2,163 | ||||
| Gross margin, % | — | — | — | — | — | 29.46 | 27.94 | 27.88 | 27.79 | 28.34 | |||||
| EBT | — | — | — | — | — | 276 | 225 | 243 | 231 | 224 | |||||
| EBT margin, % | — | — | — | — | — | 15.91 | 13.04 | 13.20 | 12.18 | 10.35 | |||||
| Net income | — | — | — | — | — | 216 | 172 | 185 | 172 | 173 | |||||
| Depreciation | — | — | — | — | — | 82 | 74 | 73 | 69 | 80 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 16.47 | 16.55 | 17.64 | 16.64 | 16.86 | ||||
| Earnings | — | — | — | — | — | 2.05 | 1.65 | 1.73 | 1.46 | 1.30 | |||||
| Cash flow | — | — | — | — | — | 2.76 | 2.63 | 2.25 | 2.41 | 2.18 | |||||
| Capex | — | — | — | — | — | (0.40) | (0.44) | (0.62) | (0.56) | (0.64) | |||||
| Free cash flow | — | — | — | — | — | 2.37 | 2.19 | 1.63 | 1.84 | 1.54 | |||||
| Book value | — | — | — | — | — | 0.00 | 9.40 | 11.14 | 2.46 | 3.13 | |||||
| Shares, m | — | — | — | — | — | 105 | 104 | 104 | 114 | 128 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 11.17 | 11.17 | 11.17 | 13.10 | 15.14 | ||||
| P/S | — | — | — | — | — | 1.24 | 1.24 | 1.24 | 1.19 | 1.17 | |||||
| P/B | — | — | — | — | — | 1.87 | 1.87 | 1.87 | 8.05 | 6.30 | |||||
| EV/Sales | — | — | — | — | — | 1.44 | 1.44 | 1.44 | 1.87 | 1.86 | |||||
| EV/FCF | — | — | — | — | — | 15.24 | 15.24 | 15.24 | 16.90 | 20.32 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 291 | 274 | 234 | 275 | 279 | ||||
| Capex | — | — | — | — | — | (42) | (46) | (65) | (64) | (82) | |||||
| Free cash flow | — | — | — | — | — | 249 | 228 | 169 | 210 | 198 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | 5 | 20 | 130 | 46 | ||||
| Total debt | — | — | — | — | — | — | 636 | 475 | 1,479 | 1,574 | |||||
| Net debt | — | — | — | — | — | — | 598 | 443 | 1,296 | 1,494 | |||||
| Shareholders’ equity | — | — | — | — | — | — | 979 | 1,161 | 281 | 401 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | 14.52 | 7.77 | 6.86 | 6.19 | ||||
| ROIC | — | — | — | — | — | 0.00 | 10.24 | 11.21 | 12.08 | 11.01 | |||||
| ROE | — | — | — | — | — | 0.00 | 0.00 | 16.82 | 23.10 | 48.82 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Concentra Group Holdings Parent, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| PACS PACS Group, Inc. | $7.6B | 27.6× | 16.8× | +9.07% (above 0%: growing) | +45.45% (above 0%: growing) | +220.51% (above 0%: growing) | 17.07% | 7.66% | Compare |
| CHE Chemed Corporation | $6.7B | 25.7× | 20.4× | +8.80% (above 0%: growing) | +42.78% (above 0%: growing) | −43.51% (below 0%: shrinking) | 32.90% | 13.25% | Compare |
| CON Concentra Group Holdings Parent, Inc. | $5.0B | 24.9× | 17.0× | +10.03% (above 0%: growing) | +45.71% (above 0%: growing) | +91.62% (above 0%: growing) | 31.70% | 18.99% | |
| LFST LifeStance Health Group, Inc. | $4.7B | 88.3× | 58.5× | +26.08% (above 0%: growing) | n/m | +55.22% (above 0%: growing) | 35.15% | 7.04% | Compare |
| OPCH Option Care Health, Inc. | $4.7B | 23.5× | 14.1× | +1.86% (above 0%: growing) | +12.90% (above 0%: growing) | +112.36% (above 0%: growing) | 18.53% | 5.90% | Compare |
| NHC National HealthCare Corporation | $3.9B | 26.9× | 8.4× | +8.83% (above 0%: growing) | +68.63% (above 0%: growing) | −41.57% (below 0%: shrinking) | 100.00% | 11.99% | Compare |
| ACHC Acadia Healthcare Company, Inc. | $2.9B | — (loss-making) | 21.1× | −0.39% (below 0%: shrinking) | −63.64% (below 0%: shrinking) | +856.54% (above 0%: growing) | 100.00% | 10.14% | Compare |
| AVAH Aveanna Healthcare Holdings Inc. | $2.8B | 9.5× | 10.4× | +13.73% (above 0%: growing) | +46.15% (above 0%: growing) | +57.89% (above 0%: growing) | 32.59% | 11.93% | Compare |
| GRDN Guardian Pharmacy Services, Inc. | $2.5B | 37.5× | 39.5× | +2.16% (above 0%: growing) | +133.33% (above 0%: growing) | +60.83% (above 0%: growing) | 22.75% | 5.87% | Compare |
| Median of peers | $4.3B | 26.9× | 18.6× | +8.82% | +45.45% | +59.36% | 32.75% | 8.90% |
Concentra Group Holdings Parent, Inc. (CON) key facts
- Strength: Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024.
- Concentra Group Holdings Parent, Inc. (CON) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
- As of October 16, 2026, CON traded at $38.54, a market capitalization of $5.0 billion.
- Concentra Group Holdings Parent, Inc. pays an annual dividend of $0.25 per share, a yield of 0.65%, with a payout ratio of 16.1%.
- Return on equity was 48.8% and debt-to-equity 3.25.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 1.85 (grey zone) for fiscal 2025.